Emerging new therapeutic antibody derivatives for cancer treatmentShijie Jin, Liqiang Pan|Signal Transduction and Targeted Therapy|2022Cited by 432
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistanceXinlei Zhuang, Liqiang Pan|Nature Communications|2022Cited by 17
Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody–drug conjugatesXuefei Bai, Liqiang Pan|Proceedings of the National Academy of Sciences|2024Cited by 2
A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T cell-based immunotherapyYue Wu, Liqiang Pan|Molecular Therapy Oncology|2024Cited by 1